Abstract
Introduction:
This study was designed to test the hypothesis that coronary artery adaptations during the postpartum period are related to underlying reductions in endothelium-dependent relaxation and/or augmented smooth muscle vasoconstrictor responsiveness.
Methods:
In vivo experiments were performed in control (nonpregnant) and postpartum swine 35–45 days post-delivery, with isometric tension experiments performed in isolated coronary arteries from those animals.
Results:
Coronary artery rings demonstrated increases in active tension generation following incremental increases in passive stretch with no differences between groups. Endothelium-dependent relaxation to bradykinin was attenuated in arteries from postpartum swine vs. control (P < 0.005). Concentration-dependent contractions to the thromboxane A2 mimetic U46619 (0.1 nM – 1 μM) were shifted rightward (EC50 27 ± 10 nM vs. 238 ± 66 nM; P < 0.01) in arteries from postpartum swine, with no changes in maximum contractile responses (P = 0.68). Intracoronary administration of U46619 (1 nM – 1 μM) in open-chest swine decreased coronary blood flow ~45 ± 3% in nonpregnant controls but had no effect on coronary blood flow in postpartum swine. Concentration-dependent contractions to KCl (5 – 90 mM) showed a rightward shift in arteries from postpartum swine (15.6 ± 1.4 mM vs. 21.8 ± 1.9 mM; P = 0.03), with no change in maximum response. Taken together, the postpartum period is associated with reduced endothelium-dependent relaxation and responsiveness to receptor-dependent and independent vasoconstrictor stimuli.
Conclusion:
These findings indicate that chronic exposure of the coronary circulation to the pregnancy/postpartum milieu results in functional adaptations in sensitivity to paracrine/hormonal compounds that should be further explored.
Keywords: Postpartum, coronary circulation, thromboxane A2
INTRODUCTION
Recent estimates from the World Health Organization project that a woman dies every two minutes from a pregnancy or childbirth-related complication [1]. Understanding of the etiologies responsible for these maternal deaths remains poor. An especially vulnerable phase is the postpartum period, where ~53% of all deaths occur between 7 days to 1 year after delivery [2]. Cardiovascular disease is the leading cause of maternal mortality during this period, accounting for over 33% of related deaths [3]. Such casualties are typically attributed to hormonal, metabolic, and hemodynamic “stress test” on the maternal system [4, 5]. Presently, there is limited understanding of the molecular pathways/mechanisms responsible for the increased incidence of cardiovascular complications during the postpartum period.
Emerging evidence indicates that adverse cardiovascular outcomes in the postpartum period could be related, at least in part, to structural and functional adaptations in the coronary circulation. This hypothesis is supported by Hoonigberg et al. who found reductions in coronary flow reserve (CFR) in postpartum women (≤ 1 month following delivery) following either healthy or complicated pregnancies [6]. Recent data from our laboratory are consistent with this finding and support that the balance between coronary blood flow and myocardial metabolism is impaired at rest and during catecholamine-mediated increases in myocardial oxygen consumption (MVO2) in swine during the postpartum period [7]. Augmented coronary vascular resistance in postpartum swine was also associated with myocardial capillary rarefaction [7]. These initial findings are consistent with an elevated risk of ischemic heart disease during the postpartum period [8] and highlight the crucial need for further investigation.
The purpose of this study was to test the hypothesis that coronary adaptations during the postpartum period after a healthy pregnancy are related to reductions in endothelium-dependent relaxation and/or augmented smooth muscle vasoconstrictor responsiveness. This hypothesis was examined by isometric tension studies on coronary arteries isolated from control (nonpregnant) and postpartum swine during the puerperium period (35–45 days post-delivery). Based on prior evidence of postpartum alterations in vascular reactivity to potassium chloride (KCl), acetylcholine, and thromboxane A2 [9–11], we examined concentration-dependent coronary artery responses to smooth muscle depolarization to KCl (5 – 90 mM), the endothelium-dependent vasodilator bradykinin (1 nM – 1 μM) and the cyclooxygenase-derived vasoconstrictor thromboxane A2 (1 nM – 1 μM). In vivo coronary blood flow responses to intracoronary thromboxane A2 (1 nM – 1 μM) were also measured in open-chest anesthetized swine. Data from these experiments provide novel insight into functional adaptations in the coronary circulation following a healthy pregnancy.
MATERIALS AND METHODS
Swine and in vivo preparation
Comprehensive description of phenotypic variables for each group was previously published by our group [7]. All animals were housed with access to water and enrichment continuously and fed standard chow twice daily as recommended by breeder. Domestic (Yorkshire) control (non-pregnant; n = 11, 200–215 kg) and postpartum swine (35–45 days post-delivery; n = 5, 60–65 kg) were sedated with Telazol (5 mg/kg), xylazine (2.5 mg/kg), and ketamine (2.5 mg/kg, im) prior to anesthesia with buprenorphine (0.03 mg/kg, im) and alpha-chloralose (60 mg/kg, iv). Only female swine were used in this study as the postpartum period is a uniquely female condition following pregnancy. Postpartum swine produced only one litter (average size 14 ± 3). All postpartum swine lactated and weaned piglets at 28 days post-delivery. No cycling or fertility issues were observed by the breeder (Oakhill Genetics, IL).
Anesthetized swine were intubated and ventilated with O2-supplemented room air to achieve > 95% oxyhemoglobin saturation and an end tidal CO2 of ~ 40 mmHg as measured by aural pulse oximetry and inline capnography, respectively. Bilateral femoral cut downs were performed, and catheters were placed in both femoral arteries and one femoral vein. One femoral artery catheter provided continuous measurement of systemic blood pressure and heart rate, while the venous catheter allowed for administration of drugs (supplemental α-chloralose, heparin). The second femoral artery catheter was placed in a subset of control (n = 3) and postpartum (n = 2) swine and used to supply blood to an extracorporeal servo-controlled pump to perfuse the left anterior descending (LAD) coronary artery at a constant designated pressure as previously described by our laboratory [12]. Systemic hemodynamic and coronary responses to intravenous dobutamine (1 – 30 μg/kg/min) were performed in control (n = 10) and postpartum (n = 5) swine as part of a previously published investigation [7]. Following completion of experiments, animals were euthanized by electrical fibrillation and the heart excised.
Isometric tension studies
Hearts from control (n = 11) and postpartum (n = 5) swine were excised and submerged in cold (4°C) normal saline. Left circumflex coronary arteries were isolated, cut into ~3-mm rings, and mounted in water-jacketed organ baths (37°C) filled with Krebs solution containing (in mM) 118 NaCl, 5 KCl, 2.5 CaCl2, 1.2 NaH2PO4, 1.2 MgSO4, 25 NaHCO3, and 10 glucose. Repeated 5 min contractions with 60 mM KCl at successively greater internal circumferences determined the optimal passive tension required for maximal coronary artery contraction. Passive tension was increased in 1 g increments until K+-mediated increases in artery tension changed less than 20% as we have shown previously [13]. Once optimal loading conditions were determined, arteries were subjected to a KCl dose-response curve (5 – 90 mM), washed, and allowed to return to baseline tension. Select arteries were incubated with vehicle (ethanol 0.1%) or the thromboxane A2 antagonist S18886 (0.1 nM; Tocris Bioscience, Minneapolis, MN) for 15 min followed by a dose-response study to the thromboxane A2 mimetic U46619 (0.1 nM – 1 μM; Tocris Bioscience). Coronary artery responses to the endothelium-dependent vasodilator bradykinin (1 nM – 1 μM; Tocris Bioscience) were determined on stable U46619 contractions. Effects of the L-type Ca2+ channel antagonist diltiazem (1 nM – 100 μM) on U46619-mediated coronary contractions were also assessed in control arteries (n = 8).
In vivo coronary response to U46619
The LAD coronary artery was cannulated, and coronary pressure maintained at 100 mmHg by a servo-controlled roller pump system in control (n = 3) and postpartum (n = 2) swine as previously described by our laboratory [12]. Following a ~15 min stabilization period, bolus intracoronary infusions of U46619 were administered in a concentration-dependent manner (to reach coronary concentrations of 10 nM – 1 μM). Lowest values of coronary blood flow were recorded following each infusion and coronary flow allowed to stabilize for ~3 min between each dose.
Statistical analyses
Statistical analyses were performed in GraphPad Prism (version 10) and Sigma Plot (version 14.0), and comparisons were made using unpaired t-test or two-way analysis of variance (ANOVA) (Factor A: Group; Factor B: Dose) as appropriate. When significance was found with ANOVA, a Student-Newman-Keuls test was performed to identify differences between groups and/or dose levels accounting for multiple comparisons. All values are presented as mean ± SEM. For all statistical comparisons, P < 0.05 was considered statistically significant.
RESULTS
Length and endothelial-dependent characteristics
The passive tension for optimal contraction of isolated coronary arteries from control (n = 11) and postpartum (n = 5) swine was determined by incremental increases in circumferential stretch and active contraction stimulated by 60 mM KCl. No differences in active-passive tension relationships were observed between groups (Fig. 1A), as quantified by calculations of the area under the curve (Control: 1423 ± 40 vs. Postpartum: 1419 ± 29; P = 0.94), maximum active tension (Control: 91.4 ± 4.8 vs. Postpartum: 88.6 ± 3.9 mN; P = 0.68), or passive tension at optimal length (Control: 28.0 ± 1.3 vs. Postpartum: 27.2 ± 1.2 mN; P = 0.70). Endothelium-dependent relaxation to bradykinin was significantly attenuated in coronary arteries from postpartum swine at concentrations ranging from 10 nM to 1 μM (Fig. 1B; P < 0.005). Maximal coronary relaxation to 1 μM bradykinin averaged 71 ± 5% in control (n = 5) vs. 54 ± 3% in postpartum (n = 4) arteries. A significant rightward shift in endothelium-dependent relaxation was observed, as the EC50 increased from 5 ± 3 nM in control arteries to 501 ± 408 nM in arteries from postpartum swine (Fig. 1C, P < 0.005).
Figure 1.

A) Active-passive tension relationship of all coronary arteries used for reactivity studies (Control; n = 11, Postpartum; n= 5). B) Bradykinin dose-response relaxation in control (closed circles; n = 5) and postpartum (open circles; n = 4) coronary arteries. C) LogEC50 of bradykinin-mediated relaxation. A, B) Two-way ANOVA with Student-Newman-Keul post-hoc test. C) Student t-test. *P < 0.05 vs. Control.
Thromboxane A2-induced coronary artery contraction
Coronary responses to thromboxane A2 were assessed by dose-response studies to the thromboxane mimetic U46619 (1nM to 1μM). U46619-induced contractions were attenuated in postpartum arteries at 10 – 100 nM (Fig. 2A; P < 0.05), and the EC50 was shifted significantly rightward from 27 ± 10 nM in control arteries (n = 6) to 238 ± 66 nM in arteries from postpartum swine (n = 5) (Fig. 2B, P = 0.008). However, maximum contractions to 1μM U46619 were not different between groups (Control: 106 ± 8 mN vs. Postpartum: 112 ± 20 mN; P = 0.77). Validation studies demonstrated that the L-type calcium channel blocker diltiazem produced concentration-dependent reductions in U46619 contractions up to 88 ± 2% in nonpregnant swine (Fig. 2C; n = 8). Maximum contractions in control arteries with incubation of vehicle or S18886 (Fig. 2D; P < 0.01) and in postpartum arteries with incubation of vehicle or S18886 (Fig. 2E; P < 0.001) are shown in Figure 2. Changes in EC50 of Control + vehicle 24 ± 4 nM vs. Control + S18886 174 ± 3 nM (P < 0.01) and postpartum + vehicle 112 ± 4 nM vs. postpartum + S18886 22 ± 3 μM (P < 0.01) were calculated from data shown in Fig 2 D and E.
Figure 2.

A) Dose-response contraction to Thromboxane A2 receptor agonist U46619 in control (n = 6) and postpartum coronary arteries (n = 5). B) LogEC50 of U46610 concentration response. C) Diltiazem relaxations on U46619 and K+ contractions of control coronary arteries (n = 8). Inhibition of U46619-mediated contraction with TP receptor antagonist S18886 in control (D; n = 5) and postpartum (E; n = 5) coronary arteries. A) Two-way ANOVA with Student-Newman-Keul post-hoc test. B) Student t-test. *P < 0.05 vs. Control.
Additional preliminary studies were also performed to assess coronary responses to thromboxane A2 in vivo in control (n = 3) and postpartum (n = 2) swine. As previously reported [7], initial baseline coronary blood flow was lower in postpartum (~0.23 mL/min/g) compared to control (~0.55 mL/min/g) swine (Fig. 3A). Intracoronary administration of U46619 produced concentration-dependent reductions in coronary blood flow up to an ~45 ± 3% decrease at 1 μM U46619 in control swine. In contrast, coronary blood flow was unaffected by U46619 in postpartum swine (Fig. 3B).
Figure 3.

A) Individual coronary flow responses to intracoronary bolus injections of U46619 in control (n = 3) and postpartum (35–45 days post-delivery; n = 2) swine. B) Maximum change in coronary flow at maximum (1 μM) U46619 bolus intracoronary injection.
Response to coronary vascular smooth muscle depolarization
Receptor-independent coronary contraction was evaluated in isolated coronary arteries from control (n = 5) and postpartum (n = 5) swine by constructing concentration-response curves to KCl (5 – 90 mM). Vascular smooth muscle depolarization to KCl produced concentration-dependent contractions in both groups (Fig. 4A). While maximal contractions to 90 mM KCl were similar between control (125 ± 14 mN) and postpartum (134 ± 16 mN) arteries (P = 0.68), sensitivity to K+ induced depolarization was reduced in arteries from postpartum swine as the EC50 increased from 16 ± 1 mM in control to 22 ± 2 mM in postpartum swine (Fig. 4B, P < 0.05).
Figure 4.

A) Dose-response contractions to KCl in control (n = 5) and postpartum (n =5) coronary arteries. B) EC50 of KCl concentration response curves. A) Two-way ANOVA with Student-Newman-Keul post-hoc test. B) Student t-test. *P < 0.05 vs. Control.
DISCUSSION
Major findings of the study
Understanding the mechanisms that contribute to maternal vulnerability to cardiovascular complications in the postpartum period remains quite limited. Reductions in coronary flow reserve (reactivity) are recognized to be a powerful predictor of major adverse cardiovascular events [14] and thus a potential contributing factor to increased cardiovascular morbidity and mortality in postpartum period [15]. Based on recent studies supporting impaired control of coronary blood flow during this period [6, 7], we performed a series of experiments to test the hypothesis that coronary artery adaptations during the postpartum period after a healthy pregnancy are related to reductions in endothelium-dependent relaxation and/or augmented smooth muscle vasoconstrictor responsiveness. Our findings indicate that the postpartum period after a healthy pregnancy and delivery is associated with 1) normal load-dependent increases in coronary artery contraction; 2) reductions in endothelium-dependent coronary artery relaxation; 3) attenuated coronary artery contraction to thromboxane A2 receptor activation; 4) diminished sensitivity to smooth muscle depolarization-induced contractions. Together, these data demonstrate that the postpartum period is associated with reduced endothelium-dependent relaxation and coronary artery smooth muscle responsiveness to receptor-dependent and -independent vasoconstrictor pathways
Coronary artery reactivity in postpartum period
Pregnancy and the postpartum period are accompanied by significant temporal changes in systemic hemodynamics and circulating vasoactive factors [16, 17, 9]. How these alterations impact cardiac and coronary vascular function remains poorly defined. Recent reports of impaired coronary vasodilator responsiveness in humans [6] and diminished myocardial oxygen delivery in swine [7] in the postpartum period suggest these challenges lead to reductions in the ability of specific pathways to promote relaxation or increases in the capacity of alternative pathways to promote vasoconstriction. To begin to address this question we performed a series of studies in isolated coronary artery rings from control and postpartum swine (35–45 days post-delivery).
We first examined effects of changes in active tension development by incrementally increasing passive stretch (tension) followed by stimulation with KCl. Vessels were set to a passive tension for optimal active force development, as this is critical for comparing contractile responses from different animals. [18–20]. We observed similar contractions to KCl-induced depolarization relative to passive loading conditions in control and postpartum coronary arteries (Fig 1A). Although we were unable to provide actual measures of vessel diameter, these data demonstrate that the postpartum condition does not influence preload-dependent contraction of coronary smooth muscle.
Clinical studies indicate that adverse pregnancy outcomes are associated with endothelial dysfunction [21, 22] and attenuated vasodilator capacity of the coronary circulation [15]. However, the extent to which coronary endothelial dysfunction contributes to postpartum complications remains unclear. Studies in pregnant dogs show increased endothelium-dependent dilation compared to a nonpregnant group [23]. In contrast, studies of aortas from postpartum rats show decreased contraction to phenylephrine but no difference in methacholine-induced relaxation [24]. Our findings demonstrate marked reductions in maximal relaxation (Fig 1B) and sensitivity (Fig 1C) to bradykinin in coronary arteries from postpartum vs. control swine. We postulate this response is due to a reduction in the production of nitric oxide as prior evidence supports that the postpartum period is associated with increases in asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthesis inhibitor [25]. However, alterations in other vasoactive substances (prostaglandins, hyperpolarizing factors) and/or smooth muscle sensitivity to any of these factors could contribute. While such mechanisms have been investigated in other vascular beds (carotid and mesenteric) during pregnancy and postpartum, little is known regarding the coronary vasculature [11, 26]. Accordingly, additional studies to assess the effects of postpartum on coronary responses to a nitric oxide donor (sodium nitroprusside) along with interrogation of downstream signaling pathways and end-effector ions channels are warranted. Regardless, endothelium-dependent control predominately occurs in larger upstream arteries, thereby acting to preserve vasodilator reserve in downstream coronary resistance vessels [27]. Thus, the extent to which endothelial dysfunction functionally contributes to impaired control of coronary blood flow in postpartum hearts remains to be determined.
Effects of postpartum condition on coronary responses to thromboxane A2
Thromboxane A2 is an unstable arachidonic acid metabolite that promotes platelet aggregation and smooth muscle contraction [28]. Specifically, thromboxane A2 has been shown to produce variable degrees of coronary vascular contraction depending on underlying endothelial integrity and/or the presence of myocardial ischemia [29–33]. Prior studies in humans suggest that circulating concentrations of thromboxane A2 are elevated during healthy pregnancy and the early postpartum period (5–365 days post-delivery) [34, 35]. This elevation is exacerbated in pregnancies complicated by preeclampsia [17]. Elevated thromboxane A2 biosynthesis is observed at the end of pregnancy and throughout the postpartum period to support the hypercoagulable state of delivery and beyond [36, 37]. Accordingly, we postulated that coronary artery adaptations in postpartum hearts are related, at least in part, to increases in thromboxane A2 receptor signaling.
Our findings do not support this hypothesis as the sensitivity of the coronary circulation to the thromboxane A2 mimetic U46619 was attenuated both in vitro (Fig 2A) and in vivo (Fig 3) in postpartum vs. control swine. These data corroborate consistency between isometric tension studies of isolated arteries in vitro relative to microvascular responsiveness in vivo. Furthermore, our results are consistent with previous reports of diminished thromboxane A2-induced contraction in uterine, pulmonary, and skeletal muscle arteries in a variety of species during pregnancy [38, 37, 33, 39]. Similar maximal U46619-induced contractions with a rightward shift in EC50 (Fig 2B) indicates that alterations in the postpartum coronary circulation occur downstream of the thromboxane receptor (TP). Impairment of downstream TP signaling is supported by similar reductions in U46619-induced contractions to the TP receptor antagonist S18886 in control (Fig 2C) and postpartum (Fig 2D) arteries. These findings, along with results demonstrating U46619-mediated contractions are inhibited by the L-type Ca2+ channel inhibitor diltiazem suggest that pregnancy/postpartum period diminish Ca2+ sensitivity of coronary vascular smooth muscle [40].
Coronary Ca2+ sensitivity in postpartum period
TP receptor signaling occurs via inositol triphosphate-mediated increases intracellular [Ca2+] [28]. To assess the effects of the postpartum condition on the sensitivity of vascular smooth muscle to increases in intracellular [Ca2+] we examined concentration-dependent coronary responses to KCl. Essentially identical maximal coronary contractions to smooth muscle depolarization at 90 mM KCl (Fig 4A) indicates similar voltage-gated (L-type) Ca2+ channel abundance and activity in control and postpartum arteries. However, the increase in the EC50 of the KCl response (Fig 4B) implicates reductions in Ca2+ sensitivity in the postpartum coronary circulation. Our group has previously documented a role for voltage-gated K+ (KV) channels and electromechanical coupling with L-type Ca2+ channels in the control of coronary blood flow [41] and as pathway for coronary dysfunction in the setting of obesity [13]. To this end, augmented abundance or activity of smooth muscle KV channels in postpartum arteries could also contribute to the rightward shift of U46619 and KCl-induced coronary contractions. However, a prior study of uterine arteries found augmented myogenic tone was related to diminished, not augmented KV channel activity [42]. Further, studies in pregnant rat uterine arteries showed sensitivity to U46619-induced contraction was not different compared to nonpregnant controls, but the contribution of protein kinase C (PKC) and Rho kinase downstream signaling to these contractions were reduced in arteries from pregnant rats compared to nonpregnant controls [39]. Studies in smooth muscle cells suggest that TP receptor isoforms lead to different downstream functions in the contractile signaling pathway [43]. Swine have one identified TP receptor isoform that is most like the human TPα which is known for contributing to vascular tone through Rho signaling [44]. Taken together, the extent to which Ca2+ sensitivity, K+ channels and/or alterations in other potential signaling mechanisms (i.e., PKC, Rho/ROCK, MLCK) contribute to the postpartum coronary phenotype merits further investigation.
Limitations of the study
The disparity in weight between the control (50–60 kg) and postpartum (200–215 kg) swine is acknowledged and related to differences in age between the non-pregnant control group (~5 months) vs. the postpartum group (~18 months) as well as the weight gain associated with gestation (average litter size 14 piglets). This issue was extensively addressed in our recent in vivo study [7] wherein diminished coronary flow responses in postpartum swine were highly consistent with a study from the Di Carli’s laboratory in postpartum women [6]. This finding along with similarities in active-passive tension relationship (Fig 1A) and maximal coronary contractions to U46619 (Fig 2A) and K+ (Fig 4A) in control and postpartum coronary arteries support that differences in age and size of swine did not result in wholesale changes in coronary reactivity. We also acknowledge that the small sample size of the in vivo study (n = 2) as a limitation and for this reason did not perform/report any statistical analyses of these data. The intent of these initial studies was to provide preliminary evidence of the directional consistency between ex vivo isometric tension responses to U46619 in isolated coronary arteries and in vivo coronary flow responses to the same thromboxane A2 mimetic.
Implications and conclusions
In conclusion, our findings support that the postpartum period is associated with functional adaptations in the coronary circulation that attenuate endothelium-dependent relaxation as well as smooth muscle contraction. We speculate that these alterations are related to progressive changes in the postpartum vasoactive milieu that favor vasoconstriction. This reduced responsiveness could mitigate the possibility of an overcorrection in the increase in vascular resistance following delivery [35]. While literature detailing coronary reactivity during pregnancy and following delivery is sparse, recent data from our laboratory indicate that coronary blood flow and myocardial oxygen delivery are reduced in swine during the postpartum period [7]. Accordingly, decreases in sensitivity of coronary smooth muscle contraction could represent a protective adaptation, without which the risk of myocardial ischemia and adverse coronary events would be further increased. If this adaptation extends to the systemic circulation, it could mitigate a hypertensive response and adverse responses to circulating clotting factors known to be increased during pregnancy and the early postpartum period [36, 45]. Alternatively, it is important to recognize that reductions in sensitivity of smooth muscle contraction are not consistent with diminished myocardial perfusion [6, 7] and/or increases in postpartum mortality [46]. These findings suggest that chronic exposure of the coronary circulation to the pregnancy/postpartum milieu results in functional adaptations in sensitivity to paracrine/hormonal compounds that should be further explored.
Sources of Funding
This work was funded by the National Institutes of Health Grant R01 HL158723 and the American Heart Association Pre-Doctoral Fellowship Grant to SMT 23PRE1012811.
Footnotes
Disclosures
The authors have no conflicts of interest to disclose.
Statement of Ethics
The protocol for this investigation was approved by the University of North Texas Health Science Center Institutional Animal Care and Use Committee (IACUC 2023-0025, March 9, 2023) and performed in accordance with the Guide for the Care and Use of Laboratory Animals. No human participants were involved in this study.
Data Availability
The data that support the findings of this study are openly available via figshare at: https://doi.org/10.6084/m9.figshare.27941364.v1 Further enquiries can be directed to the corresponding author.
REFERENCES
- 1.WHO U, UNFPA, World Bank Group and UNDESA/Population Division. Geneva: World Health Organization. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. World Health Organization2023. [Google Scholar]
- 2.Prevention CoDCa. Four in 5 pregnancy-related deaths in the U.S. are preventable CDC Newsroom2022. [Google Scholar]
- 3.Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016. Jan 30;387(10017):462–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovasc Res. 2014. Mar 15;101(4):561–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Luther JP, Johnson DY, Joynt Maddox KE, Lindley KJ. Reducing Cardiovascular Maternal Mortality by Extending Medicaid for Postpartum Women. Journal of the American Heart Association. 2021;10(15):e022040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Honigberg MC, Economy KE, Pabón MA, Wang X, Castro C, Brown JM, et al. Coronary Microvascular Function Following Severe Preeclampsia. Hypertension. 2024. Jun;81(6):1272–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tucker SM, Essajee SI, Warne CM, Dick GM, Heard MP, Crowe N, et al. Impaired balance between coronary blood flow and myocardial metabolism in postpartum swine. Journal of Molecular and Cellular Cardiology. 2024. 2024/09/01/;194:96–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lameijer H, Kampman MA, Oudijk MA, Pieper PG. Ischaemic heart disease during pregnancy or post-partum: systematic review and case series. Neth Heart J. 2015. May;23(5):249–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens. 2014. Apr;32(4):849–56. [DOI] [PubMed] [Google Scholar]
- 10.Morris EA, Mandala M, Ko NL, Osol G. Postpartum Persistence of Maternal Uterine Vascular Gestational Adaptation in Rodents. Reprod Sci. 2020. Feb;27(2):611–20. [DOI] [PubMed] [Google Scholar]
- 11.Gokina NI, Fairchild RI, Bishop NM, Dawson TE, Prakash K, Bonney EA. Kinetics of Postpartum Mesenteric Artery Structure and Function Relative to Pregnancy and Lactation in Mice. Reprod Sci. 2021. Apr;28(4):1200–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Warne CM, Essajee SI, Tucker SM, Figueroa CA, Beard DA, Dick GM, et al. Oxygen-sensing pathways below autoregulatory threshold act to sustain myocardial oxygen delivery during reductions in perfusion pressure. Basic Res Cardiol. 2023. Mar 29;118(1):12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Berwick ZC, Dick GM, O’Leary HA, Bender SB, Goodwill AG, Moberly SP, et al. Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity. Basic Res Cardiol. 2013. Sep;108(5):370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Guerraty MA, Rao HS, Anjan VY, Szapary H, Mankoff DA, Pryma DA, et al. The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes. PLoS One. 2020;15(2):e0228931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Park K, Quesada O, Cook-Wiens G, Wei J, Minissian M, Handberg EM, et al. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study. J Womens Health (Larchmt). 2020. Apr;29(4):487–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ilson GJ, Samaan S, Crawford MH, Qualls CR, Curet LB. Changes in Hemodynamics, Ventricular Remodeling, and Ventricular Contractility During Normal Pregnancy: A Longitudinal Study. Obstetrics & Gynecology. 1997;89(6):957–62. [DOI] [PubMed] [Google Scholar]
- 17.Perneby C, Vahter M, Akesson A, Bremme K, Hjemdahl P. Thromboxane metabolite excretion during pregnancy--influence of preeclampsia and aspirin treatment. Thromb Res. 2011. Jun;127(6):605–6. [DOI] [PubMed] [Google Scholar]
- 18.Sparks HV Jr., Bohr DF. Effect of stretch on passive tension and contractility of isolated vascular smooth muscle. Am J Physiol. 1962. May;202:835–40. [DOI] [PubMed] [Google Scholar]
- 19.Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977. Jul;41(1):19–26. [DOI] [PubMed] [Google Scholar]
- 20.Davis MJ, Gore RW. Length-tension relationship of vascular smooth muscle in single arterioles. American Journal of Physiology-Heart and Circulatory Physiology. 1989;256(3):H630–H40. [DOI] [PubMed] [Google Scholar]
- 21.Quinton AE, Peek MJ, Cook CM, Kirby A. Flow-mediated dilatation assessment in women with preeclampsia compared to women with gestational hypertension. Hypertens Pregnancy. 2012;31(4):377–86. [DOI] [PubMed] [Google Scholar]
- 22.Vieira MC, da Cunha Filho EV, Paula LG, Hentschke MR, Poli-de-Figueiredo CE, Pinheiro da Costa BE. Flow-mediated dilatation of brachial artery as marker of preeclampsia morbidity. Int J Cardiol. 2013. Oct 9;168(4):4424–5. [DOI] [PubMed] [Google Scholar]
- 23.Williams JG, Rincon-Skinner T, Sun D, Wang Z, Zhang S, Zhang X, et al. Role of nitric oxide in the coupling of myocardial oxygen consumption and coronary vascular dynamics during pregnancy in the dog. Am J Physiol Heart Circ Physiol. 2007. Oct;293(4):H2479–86. [DOI] [PubMed] [Google Scholar]
- 24.Morton JS, Care AS, Kirschenman R, Cooke CL, Davidge ST. Advanced Maternal Age Worsens Postpartum Vascular Function. Front Physiol. 2017;8:465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kolovetsiou-Kreiner V, Moertl MG, Papousek I, Schmid-Zalaudek K, Lang U, Schlembach D, et al. Maternal cardiovascular and endothelial function from first trimester to postpartum. PLoS One. 2018;13(5):e0197748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Gokina NI, Fairchild RI, Prakash K, DeLance NM, Bonney EA. Deficiency in CD4 T Cells Leads to Enhanced Postpartum Internal Carotid Artery Vasoconstriction in Mice: The Role of Nitric Oxide. Front Physiol. 2021;12:686429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jones CJ, Kuo L, Davis MJ, Chilian WM. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res. 1995. May;29(5):585–96. [PubMed] [Google Scholar]
- 28.Nakahata N Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther. 2008. Apr;118(1):18–35. [DOI] [PubMed] [Google Scholar]
- 29.Laurindo FRM, Finton CK, Ezra D, Czaja JF, Feuerstein GZ, Goldstein RE. Inhibition of eicosanoid-mediated coronary constriction during myocardial ischemia. The FASEB Journal. 1988;2(9):2479–86. [DOI] [PubMed] [Google Scholar]
- 30.Nichols WW, Mehta JL, Thompson L, Donnelly WH. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Am J Physiol. 1988. Jul;255(1 Pt 2):H153–9. [DOI] [PubMed] [Google Scholar]
- 31.Szwajkun K, Lamping KG, Dole WP. Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo. Circ Res. 1990. Jun;66(6):1729–37. [DOI] [PubMed] [Google Scholar]
- 32.Bache RJ, Dai XZ. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Cardiovasc Res. 1992. Apr;26(4):351–6. [DOI] [PubMed] [Google Scholar]
- 33.Feng J, Liu Y, Chu LM, Clements RT, Khabbaz KR, Robich MP, et al. Thromboxane-induced contractile response of human coronary arterioles is diminished after cardioplegic arrest. Ann Thorac Surg. 2011. Sep;92(3):829–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ylikorkala O, Viinikka L. Thromboxane A2 in pregnancy and puerperium. BMJ. 1980;281(6255):1601–02. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Goeschen K, Henkel E, Behrens O. Plasma prostacyclin and thromboxane concentrations in 160 normotensive, hypotensive, and preeclamptic patients during pregnancy, delivery, and the post partum period. J Perinat Med. 1993;21(6):481–9. [DOI] [PubMed] [Google Scholar]
- 36.Hayashi M, Inoue T, Hoshimoto K, Hirabayashi H, Negishi H, Ohkura T. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. Acta Obstet Gynecol Scand. 2002. Mar;81(3):208–13. [DOI] [PubMed] [Google Scholar]
- 37.Ungvari Z, Brown G, Venuto R, Koller A, Losonczy G. Increased NO-mediated and reduced TxA2-dependent responses in skeletal muscle arterioles in pregnancy. Hypertens Pregnancy. 2002;21(2):135–46. [DOI] [PubMed] [Google Scholar]
- 38.Losonczy G, Brown G, Mucha I, Klocke R, Muller V, Merkely B, et al. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism. Am J Physiol. 1997. Jun;272(6 Pt 2):R1734–9. [DOI] [PubMed] [Google Scholar]
- 39.Goulopoulou S, Hannan JL, Matsumoto T, Webb RC. Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery. Am J Physiol Heart Circ Physiol. 2012. Jun 15;302(12):H2477–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sakuma I, Akaishi Y, Tomioka H, Sato A, Kitabatake A, Hattori Y. Interactions of sildenafil with various coronary vasodilators in isolated porcine coronary artery. Eur J Pharmacol. 2002. Feb 22;437(3):155–63. [DOI] [PubMed] [Google Scholar]
- 41.Goodwill AG, Noblet JN, Sassoon D, Fu L, Kassab GS, Schepers L, et al. Critical contribution of KV1 channels to the regulation of coronary blood flow. Basic Res Cardiol. 2016. Sep;111(5):56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Telezhkin V, Goecks T, Bonev AD, Osol G, Gokina NI. Decreased function of voltage-gated potassium channels contributes to augmented myogenic tone of uterine arteries in late pregnancy. Am J Physiol Heart Circ Physiol. 2008. Jan;294(1):H272–84. [DOI] [PubMed] [Google Scholar]
- 43.Wikström K, Kavanagh DJ, Reid HM, Kinsella BT. Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide. Cell Signal. 2008. Aug;20(8):1497–512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Santhosh KT, Sikarwar AS, Hinton M, Chelikani P, Dakshinamurti S. Thromboxane receptor hyper-responsiveness in hypoxic pulmonary hypertension requires serine 324. British Journal of Pharmacology. 2014;171(3):676–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Fakhouri F, Scully M, Provôt F, Blasco M, Coppo P, Noris M, et al. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood. 2020. Nov 5;136(19):2103–17. [DOI] [PubMed] [Google Scholar]
- 46.Dol J, Hughes B, Bonet M, Dorey R, Dorling J, Grant A, et al. Timing of maternal mortality and severe morbidity during the postpartum period: a systematic review. JBI Evid Synth. 2022. Aug 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are openly available via figshare at: https://doi.org/10.6084/m9.figshare.27941364.v1 Further enquiries can be directed to the corresponding author.
